Clinical Trial

Clinical and Radiographic Success of Pulpotomy Using Neoputty Mineral Trioxide Aggregate Versus Pulpectomy Using Endoflas In Primary Molars With Irreversible Pulpitis: A Randomized Controlled Trial

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 10, 2025 (before its estimated May 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this randomized clinical trial is to evaluate the clinical and radiographic success of pulpotomy using Neoputty MTA vital primary molars diagnosed with symptomatic irreversible pulpitis. The main question it aims to answer is: Will Neoputty MTA pulpotomy have higher clinical and radiographic success in comparison to Endoflas pulpectomy in primary molars with irreversible pulpitis?
Trial Details
NCT Number NCT06922578
Lead Sponsor Cairo University
Conditions Pulpitis - Irreversible
Enrollment 66 participants
Start Date 2025-05-01
Primary Completion 2026-05-01 (estimated)
Study Completion 2026-06-01 (estimated)
Updated on ClinicalTrials.gov 2025-04-10